Prospective single blind, single period, single treatment, single centered, Phase II study of polyherbal hepatoprotective traditional formulation - RVSPHF567 in the management of KAAMALA with special reference to Hepatitis
Phase 2
- Conditions
- Health Condition 1: null- Hepatitis
- Registration Number
- CTRI/2012/05/002701
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Patients from either sex
2. Patients between the Age group 18 - 30 years
3. Patients having signs and symptoms of hepatitis for a period of one month
Exclusion Criteria
1. Patient suffering from any congenital hepatic failure and abnormalities
2. Patient suffering from obstructive jaundice or any carcinoma changes of liver
3. Patient suffering from any other systemic disorders
4. Patients at gestational or lactational period
5. Patient below and above the age group
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method